SecBot SecBot
144 ·Filed May 11, 2026

COLL

COLLEGIUM PHARMACEUTICAL, INC
NEUTRAL
Impact 2/10
Horizondays Processed6mo ago SEC0001959173-26-003457
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine insider intent-to-sell filing by a director. The dollar amount is immaterial relative to market cap. No immediate trading action warranted. Monitor for any subsequent Form 4 filings to confirm execution.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$35.81
T+0 close · May 11, 2026 · via day close
Latest settled
−0.20%
T+60 · $35.74
Vs SPY
−4.59%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 11 $35.81entry
  2. T+1 · 6mo ago −0.34%α −0.20% · $35.69
  3. T+5 · 6mo ago −6.03%α −5.95% · $33.65
  4. T+20 · 5mo ago −3.94%α −3.63% · $34.40
  5. T+60 · 3mo ago −0.20%α −4.59% · $35.74
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Garen G. Bohlin filed a Form 144 notice of intent to sell 8,700 shares of Collegium Pharmaceutical common stock, valued at approximately $323,491. The sale is planned through Fidelity Brokerage Services LLC and relates to shares acquired via a 2016 option grant.

Key Facts

  • Director Garen G. Bohlin filed Form 144 to sell 8,700 shares.
  • Estimated sale value: $323,491.
  • Shares relate to a 2016 option grant.
  • Sale to be executed through Fidelity Brokerage Services LLC.
  • Filing date: May 11, 2026.

Financial Impact

Sale of 8,700 shares valued at ~$323,491, representing a small fraction of the company's $1.2B market cap.

dilution

Risk Factors

  • Insider selling may signal lack of confidence, but this is a small, routine sale by a director, not a C-suite officer.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
83% bullish (12 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-003457
Document: 0001959173-26-003457-index.html0001959173-26-003457
Document: 0001959173-26-003457.txt0001959173-26-003457

Track record

24 reports on COLL

Performance horizon

1 of 6 bullish or bearish reports moved the stock their way by T+1. Best: +0.28% at T+1 after the Aug 13, 2026 report. 1 of 6 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $25.68 Now $25.43 −0.97% settles Nov 17
  2. Nov 10, 20266d ago SC 13G/A Bearish 4/10 Entry $24.47 to $24.81 Now $25.43 −3.92% ▼ −1.39% −0.07% vs SPY
  3. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $24.47 to $24.81 Now $25.43 +3.92% ▲ +1.39% +0.07% vs SPY
  4. Nov 9, 20267d ago Institutional Cluster Bearish 4/10 Entry $24.47 to $24.81 Now $25.43 −3.92% ▼ −1.39% −0.07% vs SPY
  5. Nov 5, 202611d ago 8-K Neutral 5/10 No price data
  6. Nov 5, 202611d ago Press Release Neutral 5/10 Entry $25.16 to $24.21 Now $25.43 +1.07% ▼ −3.78% −4.09% vs SPY
  7. Oct 30, 202617d ago SC 13G/A Neutral 3/10 Entry $23.80 to $23.68 Now $25.43 +6.85% ▼ −0.50% −0.03% vs SPY
  8. Oct 29, 202618d ago SC 13G/A Neutral 3/10 Entry $24.03 to $23.80 Now $25.43 +5.83% ▼ −0.96% +0.82% vs SPY
  9. Oct 29, 202618d ago Press Release Neutral 2/10 Entry $24.03 to $23.80 Now $25.43 +5.83% ▼ −0.96% +0.82% vs SPY
  10. Oct 22, 202625d ago Press Release Neutral 1/10 Entry $23.50 to $22.96 Now $25.43 +8.21% ▼ −2.30% −1.78% vs SPY
Showing 10 of 24

US Market Status

Market Closed · Opens in 6h 36m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 11, 2026